Seelos Therapeutics, INC S-1 registration statements

Seelos Therapeutics is seeking to raise capital through a public offering of common stock and warrants to fund general corporate purposes and advance its product pipeline.

Seelos Therapeutics has filed a registration statement for the resale of up to 924,414 shares of its common stock, which are issuable upon the exercise of outstanding warrants held by selling stockholders.

Seelos Therapeutics has filed an amendment to its Form S-1 registration statement, primarily concerning the resale of common stock issuable upon the exercise of outstanding warrants.

Seelos Therapeutics is registering the resale of 3,404,256 shares of common stock issuable upon exercise of warrants previously issued to selling stockholders.